Lifecore Biomedical, Inc. (LFCR)
Nasdaq: LFCR · Pharmaceutical Preparations · Chaska, MN · filing with the SEC since 1996
Filings
339 filings since 2017 beside 372 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and smaller reporting company
10-KT
Annual report, transition period for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 24, 2026.
Filings a yearinsider forms included
96797957761035438
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 13 times in the last 36 months, the newest Jun 5, 2026.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Aug 18, 2025.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Jun 7, 2024.SEC letters: 7 in the last 36 months, the newest Sep 26, 2025.A late-filing notice, Form NT 10-K, filed Aug 12, 2024.A late-filing notice, Form NT 10-Q, filed Apr 8, 2024.A late-filing notice, Form NT 10-Q, filed Jan 10, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 28, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Sep 27, 2026
Aug 5, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Jun 5, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Jun 4, 2026
May 6, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Mar 16, 2026
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
Nov 6, 2025
8-K items 2.02, 7.01, 9.01
Results released; Investor disclosure (Regulation FD) · Current report
40 of 339 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.